메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Lee, Hyun-Jin (Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine) Song, Si-Yeol (Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine) Kwon, Tae-Won (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) Yook, Jeong-Hwan (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) Kim, Song-Cheol (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) Han, Duck-Jong (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) Kim, Choung-Soo (Department of Urology, Asan Medical Center, University of Ulsan College of Medicine) Ahn, Han-Jong (Department of Urology, Asan Medical Center, University of Ulsan College of Medicine) Chang, Heung-Moon (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) Ahn, Jin-Hee (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) Jwa, Eun-Jin (Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine) Lee, Sang-Wook (D) Kim, Jong-Hoon Choi, Eun-Kyung Shin, Seong-Soo Ahn, Seung-Do
저널정보
대한방사선종양학회 Radiation oncology journal : ROJ Radiation oncology journal : ROJ 제29권 제4호
발행연도
2011.1
수록면
260 - 268 (9page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Purpose: To evaluate the treatment outcome and prognostic factor after postoperative radiotherapy in retroperitoneal sarcoma. Materials and Methods: Forty patients were treated with surgical resection and postoperative radiotherapy for retroperitoneal sarcoma from August 1990 to August 2008. Treatment volume was judged by the location of initial tumor and surgical field, and 45-50 Gy of radiation was basically delivered and additional dose was considered to the high-risk area. Results: The median follow-up period was 41.4 months (range, 3.9 to 140.6 months). The 5-year overall survival (OS) was 51.8% and disease free survival was 31.5%. The 5-year locoregional recurrence free survival was 61.9% and distant metastasis free survival was 50.6%. In univariate analysis, histologic type (p = 0.006) was the strongest prognostic factor for the OS and histologic grade (p = 0.044) or resection margin (p = 0.032) had also effect on the OS. Histologic type (p = 0.004) was unique significant prognostic factor for the actuarial local control. Conclusion: Retroperitoneal sarcoma still remains as a poor prognostic disease despite the combined modality treatment including surgery and postoperative radiotherapy. Selective dose-escalation of radiotherapy or combination of effective chemotherapeutic agent must be considered to improve the treatment result especially for the histopathologic type showing poor prognosls.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0